#antibody — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #antibody, aggregated by home.social.
-
Meharry Medical College student Mudiare Ikoba highlights a publication in Cancer Cell by Cell Press with contributions from Priyamvada Acharya and colleagues from Duke University School of Medicine where the authors explore the utility of antibodies produced by tumor-infiltrating plasma cells to guide cancer immunotherapy strategies.
Read more here: https://medium.com/sbgrid-community-news/antibodies-guiding-cancer-immunotherapy-d56f254c79c0
-
Neutralizing #antibody #evasion of #SARS-CoV-2 #JN1 derivatives #KP3, #KP311, #LB1, and #XEC
Source: BioRxIV, AbstractThe emergence of SARS-CoV-2 variants poses ongoing challenges to vaccine efficacy. We evaluated neutralizing antibody responses against JN.1 and its derivatives (KP.3, KP.3.1.1, LB.1, and XEC) in healthcare workers who received seven doses of BNT162b2, including XBB.1.5 monovalent vaccine. In COVID-19-naive individuals, KP.3.1.1 and LB.1 showed…
-
#Neutralization and #Stability of #JN1-derived #LB1, #KP23, #KP3 and #KP311 #Subvariants http://biorxiv.org/cgi/content/short/2024.09.04.611219v1?rss=1
We report on the neutralizing #antibody (nAb) #escape, infectivity, #fusion, and stability of these subvariants-LB.1, KP.2.3, KP.3, and KP.3.1.1. Our findings demonstrate that all of these subvariants are highly evasive of nAbs elicited by bivalent #mRNA #vaccine, the #XBB15 monovalent mumps virus-based vaccine, or from infections during the BA.2.86/JN.1 wave.
-
Use of #equine #H3N8 #HA as a broadly protective #influenza #vaccine #immunogen, BioRxIV: https://www.biorxiv.org/content/10.1101/2024.08.30.610504v1
Vaccinated ferrets exhibited similar broadly reactive serum #antibody responses that protected vaccinees from clinical signs of infection & viral-induced histopathology after challenge with H1N1pdm09 virus. These data suggest that vaccination with equine H3N8 vaccine induces broad protection vs flu without need for non-influenza viral vectors, ...
-
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19.
https://sciencebusiness.technewslit.com/?p=45134
#News #Press #Science #Business #BARDA #Covid19 #SARSCoV2 #Finance #VentureCapital #Investment #Collaboration #ClinicalTrials #Challenge #Vaccines #Therapies #Antibody #Manufacturing